Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Shares Outstanding (Weighted Average): 2014-2024

Historic Shares Outstanding (Weighted Average) for Soleno Therapeutics (SLNO) over the last 11 years, with Dec 2024 value amounting to $43.1 million.

  • Soleno Therapeutics' Shares Outstanding (Weighted Average) rose 108.34% to $3.0 million in Q4 2019 from the same period last year, while for Jun 2019 it was $2.1 million, marking a year-over-year increase of 60.74%. This contributed to the annual value of $43.1 million for FY2024, which is 41.37% up from last year.
  • Latest data reveals that Soleno Therapeutics reported Shares Outstanding (Weighted Average) of $43.1 million as of FY2024, which was up 41.37% from $30.5 million recorded in FY2023.
  • In the past 5 years, Soleno Therapeutics' Shares Outstanding (Weighted Average) ranged from a high of $43.1 million in FY2024 and a low of $5.3 million during FY2020.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $27.3 million, with a median of $30.5 million in 2023.
  • Data for Soleno Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 273.79% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Soleno Therapeutics' Shares Outstanding (Weighted Average) stood at $5.3 million in 2020, then grew by 0.24% to $5.3 million in 2021, then skyrocketed by 53.36% to $8.2 million in 2022, then soared by 273.79% to $30.5 million in 2023, then soared by 41.37% to $43.1 million in 2024.